Keyphrases
Metabolomics Study
100%
Diabetic Mice
100%
Skeletal muscle
100%
Insulin Resistance
66%
Risk Factors
66%
Exercise Intensity
66%
Type 2 Diabetes Mellitus (T2DM)
66%
Positive Role
66%
Moderate Intensity
66%
Regulatory Effect
66%
Lifestyle Intervention
33%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
33%
Inflammation
33%
Hyperglycemia
33%
Lipid Metabolism
33%
Metabolic Pathway
33%
Cardiovascular Complications
33%
Purine Metabolism
33%
Mass Spectrometry-based Metabolomics
33%
Gas Chromatography-mass Spectrometry
33%
Lipids
33%
Metabolomics Approach
33%
Blood Glucose
33%
Hyperuricemia
33%
Long-chain Fatty Acids
33%
Fatty Liver
33%
Hypoxanthine
33%
Lipid Accumulation
33%
High Mortality
33%
Long-chain Acylcarnitines
33%
Metabolic Changes
33%
Hyperinsulinemia
33%
Uric Acid Clearance
33%
Diabetic Patients
33%
Uric Acid
33%
Muscle Composition
33%
Exercise Effect
33%
Inosinic Acid
33%
Human muscle
33%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Insulin Resistance
66%
Non Insulin Dependent Diabetes Mellitus
66%
Uric Acid
66%
Cardiovascular Disease
33%
Diseases
33%
Inflammation
33%
Acylcarnitine
33%
Purine
33%
Fatty Liver
33%
Hyperuricemia
33%
Hyperinsulinemia
33%
Hyperglycemia
33%
Long Chain Fatty Acid
33%
Carbon
33%
Carbon 14
33%
Inosine Phosphate
33%
Hypoxanthine
33%
Biochemistry, Genetics and Molecular Biology
Metabolite
100%
Metabolomics
100%
Skeletal Muscle
100%
Insulin Resistance
66%
Liquid Chromatography-Mass Spectrometry
33%
Hyperglycemia
33%
Mass Spectrometry
33%
Glucose Blood Level
33%
Gas Chromatography-Mass Spectrometry
33%
Lipid Metabolism
33%
Hyperuricemia
33%
Lipid Storage
33%
Inosinic Acid
33%
Purine Metabolism
33%
Lipid
33%
Immunology and Microbiology
Metabolite
100%
Skeletal Muscle
100%
Insulin Resistance
66%
Liquid Chromatography Mass Spectrometry
33%
Purine Metabolism
33%
Glucose Blood Level
33%
Lipid Metabolism
33%
Lipid Storage
33%
Muscle
33%
Gas Chromatography Mass Spectrometry
33%